Tizanidine Tablet
Product Images NDC 71610-455

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Tizanidine (NDC 71610-455). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Aphena Pharma Solutions - Tennessee, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Bottle Label 2 mg (71610 0455 09)

This is a description of a medication called Tizanidine, USP. The medication comes in a package of 9000 tablets and each tablet contains 2mg of the medication. The medication is only available with a prescription.*

FDA Label Image

Aphena Pharma Solutions (TN)

FDA Label Image

Figure-1.jpg (Figure 1)

This is a graph (Figure 1) showing the average levels of Tizanidine in the bloodstream over time for tablets and capsules (both doses of 4mg taken twice) under conditions of fasting and after eating.*

FDA Label Image

Figure-2.jpg (Figure 2)

The text describes a figure labeled "Figure 2" that presents the mean change in muscle tone from baseline, as measured by the Ashworth Scale with 95% confidence intervals. The scale scores a decrease in muscle tone from baseline as a negative Ashworth score signifying an improvement. The figure shows the changes in muscle tone measured in hours post-dose for a single-dose study.*

FDA Label Image

Figure-3.jpg (Figure 3)

FDA Label Image

Chemical-structure (Tizanidine Imtb 01)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.